Principles and Terminology for Host–Microbiome–Drug Interactions
Open Access
- 12 April 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (5) , ofad195
Abstract
Interactions between the microbiome and medical therapies are distinct and bidirectional. The existing term “pharmacomicrobiomics” describes the effects of the microbiome on drug distribution, metabolism, efficacy, and toxicity. We propose that the term “pharmacoecology” be used to describe the effects that drugs and other medical interventions such as probiotics have on microbiome composition and function. We suggest that the terms are complementary but distinct and that both are potentially important when assessing drug safety and efficacy as well as drug–microbiome interactions. As a proof of principle, we describe the ways in which these concepts apply to antimicrobial and non-antimicrobial medications.Keywords
This publication has 58 references indexed in Scilit:
- The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enemaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Mechanistic insight into digoxin inactivation byEggerthella lentaaugments our understanding of its pharmacokineticsGut Microbes, 2014
- Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lentaScience, 2013
- Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbesGut Pathogens, 2012
- A framework for human microbiome researchNature, 2012
- Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthmaEMBO Reports, 2012
- Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis PatientsAntimicrobial Agents and Chemotherapy, 2010
- Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Digoxin-Inactivating Bacteria: Identification in Human Gut FloraScience, 1983
- Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic TherapyNew England Journal of Medicine, 1981